National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 3) (PB 35 of 2015) (Cth)

PB 35 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 3)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                26         March 2015

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 3).

   (2)   This Determination may also be cited as PB 35 of 2015.

2. Commencement

   This Determination commences on 1 April 2015.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Albendazole

Insert

Alemtuzumab

[2]     Schedule 1, after item dealing with Amino acids – synthetic, formula

Omit

Amitriptyline

[3]     Schedule 1, after item dealing with Dornase alfa

Omit

Dorzolamide

[4]     Schedule 1, after item dealing with Imatinib

Insert

IncobotulinumtoxinA

[5]     Schedule 1, after item dealing with Midazolam

Omit

Mifepristone

Insert

Mifepristone and misoprostol

[6]     Schedule 1, after item dealing with Nedocromil

Omit

Nicorandil

[7]     Schedule 1, after item dealing with Oestriol

Insert

Ofatumumab

[8]     Schedule 1, after item dealing with Oxprenolol

Insert

Oxytocin

[9]     Schedule 1, after item dealing with Strontium

Insert

Sucroferric oxyhydroxide

[10]   Schedule 1, after item dealing with Umeclidinium

Omit

Ursodeoxycholic acid

[11]   Schedule 2, after item dealing with Amisulpride

Insert

Amitriptyline

[12]   Schedule 2, after item dealing with Donepezil

Insert

Dorzolamide

[13]   Schedule 2, after item dealing with Mirtazapine

Omit

Misoprostol

[14]   Schedule 2, after item dealing with Nevirapine

Insert

Nicorandil

[15]   Schedule 2, after item dealing with Tropisetron

Insert

Ursodeoxycholic acid